Repligen (RGEN) Accumulated Expenses (2011 - 2026)

Repligen (RGEN) has 16 years of Accumulated Expenses data on file, last reported at $65.3 million in Q1 2026.

• On a quarterly basis, Accumulated Expenses rose 177.52% year-over-year to $65.3 million in Q1 2026; TTM through Mar 2026 was $65.3 million, a 177.52% increase from a year earlier, with the FY2025 full-year figure at $79.2 million, up 146.27% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $65.3 million, down from $79.2 million in the prior quarter.
• Over the last five years, Accumulated Expenses for RGEN reached as high as $79.2 million in Q4 2025 and fell as low as $23.5 million in Q1 2025.
• Historically, Accumulated Expenses has averaged $55.5 million across 5 years, with a median of $59.2 million in 2024.
• Across the five-year window, Accumulated Expenses slumped 60.28% in 2025 and surged 177.52% in 2026, its largest moves.
• Year by year, Accumulated Expenses stood at $71.1 million in 2022, then decreased by 19.41% to $57.3 million in 2023, then sank by 43.88% to $32.2 million in 2024, then soared by 146.27% to $79.2 million in 2025, then declined by 17.62% to $65.3 million in 2026.
• Per Business Quant data, the three most recent Accumulated Expenses figures were $65.3 million in Q1 2026, $79.2 million in Q4 2025, and $36.0 million in Q3 2025.